Molybdenum for Health & Longevity - Quick Reference Sheet

Molybdenum for Health & Longevity

Created on 06/28/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 4.8 Audit

An essential trace mineral that runs a few clean-up enzymes, most importantly one that clears sulfite, a reactive by-product of breaking down protein. Plentiful in legumes, grains, nuts, and water, so genuine shortage is almost unheard of outside rare medical situations. Ordinary food supplies what the body needs, with no clear added benefit from more, while too much lowers copper. (Full Review)

Protocol

Standard Approach
Dietary adequacy
Adult RDA 45 µg/day; most diets supply 75–250 µg/day, so deficiency is not a practical concern
Supplemental Forms and Typical Doses
50–500 µg per dose
Sodium/ammonium molybdate, glycinate, or picolinate, usually inside a multimineral; supplementation generally not needed
Best Time of Day
With food
No clinically meaningful time-of-day effect; typically taken alongside other minerals in a multivitamin
Time to effect
Correction of Deficiency
Days
In genuine deficiency, correcting molybdenum resolves the metabolic disturbance over days
Replete Adult
No perceptible effect
Requirements are already met, so there is no effect to await

Benefits

Contraindications
  • Wilson disease being managed for copper
  • Diagnosed or at-risk copper deficiency
  • Significant kidney impairment (reduced clearance)
  • On copper-lowering therapy
  • Pregnancy and breastfeeding (high supplemental doses)
Key Interactions
  • Copper (supplements and copper-containing formulas)
  • Copper-lowering drugs (tetrathiomolybdate, penicillamine, trientine, zinc therapy)
  • High-sulfur / sulfite-containing intake
  • Other trace-mineral supplements (iron, zinc)
  • Over-the-counter products (antacids, high-dose mineral products)

Risk & Side Effects

  • High: Copper depletion at high intakes
  • Medium: Gout-like / elevated uric acid and joint symptoms
  • Low: Gastrointestinal and general tolerability
  • Speculative: Cardiovascular signal from observational metal studies; reproductive and hormonal effects at high exposure

Monitoring

Marker Target Why
Serum copper ~80–155 µg/dL (functional mid-range preferred) Detect copper depletion from high molybdenum
Ceruloplasmin ~20–35 mg/dL Functional copper status, more stable than serum copper
Uric acid ~3.5–5.5 mg/dL (functional); women lower end Molybdenum-dependent xanthine oxidase affects uric acid
eGFR / creatinine eGFR >90 mL/min/1.73 m² Molybdenum is renally cleared; impaired clearance raises retention
Complete blood count Within standard reference range Copper depletion can cause anemia/neutropenia

Cadence: Only if high-dose molybdenum is used or risk factors are present: copper status and uric acid at ~3 months after starting, then every 6–12 months; review kidney function every 6–12 months in older adults or those with renal concerns

Qualitative Assessment

  • General energy and well-being (nonspecific; true deficiency is rare)
  • Tolerance of sulfite-containing foods or wine (anecdotally cited, not validated)
  • Absence of new joint pain or gout-like symptoms when intake is high
  • Neurological well-being (numbness, cognitive changes can accompany copper depletion)